🇺🇸 Twist Bioscience Corporation
Forum topic · TWST · Company page: financials, ownership and filings
Join the discussion on Twist Bioscience Corporation
Loading…
Annual report filed (10-K)
Twist Bioscience Corporation filed its annual report (Form 10-K) for the year ended 30 September 2026 with the SEC on 16 November 2026.
The financial statements from it are on the company's page.
Results announced on 12 November 2026
Twist Bioscience Corporation announced results on 12 November 2026 (SEC Form 8-K, item 2.02).
Insider trading in October 2026
Directors and officers of Twist Bioscience Corporation reported open-market trades for October 2026 (SEC Forms 4 and 5): 6 insiders sold shares worth about $20,737,379 in 17 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 293 funds hold $3.1 billion
293 mutual funds in 2 countries hold shares of Twist Bioscience Corporation worth $3.1 billion, about 38.3% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 176 funds added shares and 99 sold; on balance they bought $256 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.